[PDF][PDF] Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines

WJ Yao, CK Hoh, RA Hawkins, JA Glaspy… - Journal of Nuclear …, 1995 - Soc Nuclear Med
+ R24 groups, rapid increases in bone marrow glucose mets bohcrateswere
observedduringtherapy. After GMCSFwas stopped, bone marrow glucose metabolicrates …

[PDF][PDF] Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results

Y Sugawara, KR Zasadny, PV Kison… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Departments oflnternal Medicine and Radiology, Divisions ofNuclear Medicine and
Hematology/Oncology, University ofMichigan Medical Center@ Ann Arbor@ Michigan other …

Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT

Y Murata, K Kubota, M Yukihiro, K Ito… - Nuclear medicine and …, 2006 - Elsevier
The aim of this study was to investigate the correlations between 18F-FDG uptake by bone
marrow and various hematological parameters. Forty-eight patients who underwent FDG …

Use of insulin to improve [18F] fluorodeoxyglucose labelling and retention for in vivo positron emission tomography imaging of monocyte trafficking

JY Paik, KH Lee, SS Byun, YS Choe… - Nuclear medicine …, 2002 - journals.lww.com
While 18 F-FDG labelling of monocytes would allow in vivo trafficking with positron emission
tomography (PET), present methods suffer from poor retention of radioactivity. We …

[HTML][HTML] Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging

C Sachpekidis, H Goldschmidt, K Kopka… - EJNMMI research, 2018 - Springer
Background Despite the significant upgrading in recent years of the role of 18 F-FDG
PET/CT in multiple myeloma (MM) diagnostics, there is a still unmet need for myeloma …

Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma

K Hanaoka, M Hosono, K Usami… - Nuclear medicine …, 2011 - journals.lww.com
Purpose To clarify the change in the fluorodeoxyglucose (FDG) uptake by the bone marrow
over time after administration of granulocyte colony-stimulating factor (G-CSF), we evaluated …

Spleen glucose metabolism on [18F]-FDG PET/CT: a dynamic double-edged biomarker predicting outcome in cancer patients

RD Seban, L Champion, LH Schwartz… - European Journal of …, 2021 - Springer
Dear Sir, We have read with great interest the manuscript “Assessing immune organs on
[18F]-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter …

Effect of colony-stimulating factor and conventional-or high-dose chemotherapy on FDG uptake in bone marrow

T Kazama, N Swanston, DA Podoloff… - European journal of …, 2005 - Springer
Purpose Granulocyte or granulocyte-macrophage colony stimulating factor (CSF), usually
used in conjunction with chemotherapy, may interfere with the 18 F-fluorodeoxyglucose …

[HTML][HTML] Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation

JP Pijl, PH Nienhuis, TC Kwee… - Seminars in Nuclear …, 2021 - Elsevier
White blood cells activated by either a pathogen or as part of a systemic inflammatory
disease are characterized by high energy consumption and are therefore taking up the …

Age-Related Changes in the Metabolic Activity and Distribution of the Red Marrow as Demonstrated by 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission …

C Fan, M Hernandez-Pampaloni, M Houseni… - Molecular imaging and …, 2007 - Springer
Objectives The objective of the study was to determine age-related changes occurring in red
marrow with regard to its distribution and the degree of its metabolic activity by whole-body 2 …